Physician profile
Molly Silkowski
NPI 1225534191
$6,065.49
in general payments reported to CMS, 2019-2025
11 companies · $4,715 in 2025
The $4,715 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.76 · 2023: $497 · 2024: $835 · 2025: $4,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,244 · Food and Beverage: $2,631 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,243.63 |
| Food and Beverage | $2,630.75 |
| Education | $172.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,032.14 | 2024-2025 | 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Edwards Lifesciences Corporation | $1,885.36 | 2022-2025 | Sapien 3 Ultra Resilia, Hemosphere, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $431.37 | 2023-2024 | Rotablator Rotational Atherectomy System Console Kit, Opticross, Watchman Flx |
| Abiomed | $253.60 | 2025 | |
| Teleflex LLC | $180.17 | 2025 | Guideliner |
| Medtronic, INC. | $165.15 | 2025 | Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $36.18 | 2024 | Winrevair |
| Novartis Pharmaceuticals Corporation | $27.16 | 2025 | |
| Angiodynamics, INC. | $22.22 | 2025 | Alphavac |
| Innovation Technologies INC | $16.75 | 2025 | Irrisept |
| Terumo Medical Corporation | $15.39 | 2025 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Silkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.